Shareholder & Partnership Protection
If your business partner or a shareholder died or became critically ill, have you ever thought what the impact could be?
The loss of a business partner or a shareholder can have a major impact on the success of any business. But it’s not just about the loss of profits the business could suffer. Who would take their place? Not only in performing their day- to-day duties, but also in making decisions of how your business is run in the future.
Importance of obtaining professional advice
Each person should be covered for their share's full value, which should be regularly reviewed to ensure adequate coverage as a company's value changes.
The policy should allow for annual inflation-proofing and significant single increases without requiring further health evidence.
The business protection's structure can affect the taxation of any benefits or premiums. A business agreement should outline how funds will be used after a claim, such as a cross or single option agreement. Given that circumstances vary, it's essential to seek professional advice to establish the best arrangements.
Frequently Asked Question's
Your questions about Insurance answered.
For further questions please get in touch
What is shareholder protection for directors?
Shareholder protection is an arrangement that provides the remaining business owners with the necessary funds to buy the shares of a deceased or critically ill director from their estate or family. It typically involves a legal agreement, such as a cross-option agreement, and life or life and critical illness insurance policies.
Why is it important for directors?
Without it, several problems can arise:
• Loss of control: The shares might be inherited by a family member with no business experience or interest in being involved, or sold to an unwelcome third party, possibly even a competitor.
• Financial strain: The remaining directors may not have enough personal funds to buy the shares at a fair value, potentially forcing them to use business capital, seek loans, or even wind up the company.
• Uncertainty for the family: The deceased's family may struggle to find a buyer for the shares and receive a fair price, especially for unlisted private company shares which lack marketability.
• Business disruption: The process of dealing with an unplanned change in ownership can cause significant disruption to the company's operations and stability.
How does the process generally work?
The most common method involves these steps:
1. Valuation: The directors agree on a method to value each shareholder's interest in the business (usually with the help of an accountant).
2. Insurance: Each director takes out a life insurance policy (often with optional critical illness cover) on their own life, for the value of their shares.
3. Trust: The policies are typically written into a business trust, specifying that the surviving shareholders are the beneficiaries of the payout.
4. Legal Agreement: A formal legal document, usually a cross-option agreement (or double option agreement), is put in place. This agreement gives the remaining shareholders the option to buy the shares and the deceased's family/estate the option to sell, but neither is obligated until an option is exercised after death, which helps preserve Business Property Relief (BPR) for Inheritance Tax (IHT) purposes.
Is a legal agreement necessary in addition to the insurance?
Yes, the insurance policy provides the funds, but the legal agreement (cross-option agreement) provides the framework and rules for the share transfer, ensuring the process is followed as intended and legally binding on all parties.
Does the insurance payout have tax implications?
The lump sum payout from the insurance policy is generally free from income tax and Capital Gains Tax (CGT). If the arrangement is set up correctly as a commercial transaction using a cross-option agreement, it should also avoid IHT issues by preserving Business Property Relief (BPR) on the shares.
What happens if a director becomes critically ill?
If critical illness cover is included, a single-option agreement is usually used. This gives the critically ill shareholder the option to sell their shares to the remaining directors, but it does not force them to sell, allowing for the possibility of recovery and return to work.
